Trending
November 26, 2024

NS Pharma Announces Change in Commercial Leadership

November 22, 2024

Surendralal Karsanbhai Elected to Merck Board of Directors

November 19, 2024

Kevin Krause Appointed CEO of ArrePAth

November 14, 2024

SAI MedPartners Acquires IDEA Pharma

November 14, 2024

myBiometry Secures $5M to Seek Regulatory Sanction for Device for Asthma Patients

November 13, 2024

Virpax Pharmaceuticals Prices of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

November 12, 2024

Avalo Therapeutics Closes $69.4 Million Financing

November 12, 2024

Vittoria Biotherapeutics Completes $25 Million in Private Financing

November 8, 2024

Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results

November 7, 2024

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

November 7, 2024

Viatris Reports Third Quarter Financial Results for 2024

November 7, 2024

BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

November 7, 2024

Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist

November 6, 2024

Sonnet BioTherapeutics Prices of $5.0 Million Underwritten Public Offering

November 6, 2024

Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update

November 5, 2024

Catalent Reports First Quarter Fiscal 2025 Results